NRIX
NASDAQ · Biotechnology
Nurix Therapeutics Inc
$15.22
+0.78 (+5.40%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
+375.0% upside
Low Target
$45.76
Average Target
$72.29
High Target
$82.91
Current Price
$15.22
Current
$15.22
$15.22
Target
$72.29
$72.29
$45.76
$72.29 avg
$82.91
Scenario Analysis
Bear Case
$45.76
200.7%
Low target
Base Case
$72.29
+375.0%
Avg target
Bull Case
$82.91
+444.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$22.50
-32.4% from high
52-Week Low
$8.18
+86.1% from low
Target vs 52W High
$72.29
+221.3% vs high
Next Earnings Report
Apr 6, 2026
10d
until earnings
EPS Est: $-0.77
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |